每經AI快訊，麗(li)珠集團(tuan)晚(wan)間(jian)公(gong)(gong)(gong)告，基于(yu)謹(jin)慎性原則，對(dui)公(gong)(gong)(gong)司(si)(si)及子公(gong)(gong)(gong)司(si)(si)截至2023年(nian)(nian)12月31日公(gong)(gong)(gong)司(si)(si)合(he)并報(bao)表(biao)范圍(wei)內存(cun)(cun)在減(jian)(jian)(jian)值跡象的(de)(de)資(zi)產進行了減(jian)(jian)(jian)值測試(shi)，并對(dui)其中存(cun)(cun)在減(jian)(jian)(jian)值跡象的(de)(de)資(zi)產相(xiang)應(ying)計提(ti)了減(jian)(jian)(jian)值準備。本次(ci)需計提(ti)信(xin)用減(jian)(jian)(jian)值損失(shi)金額(e)共計1575.33萬(wan)元；需計提(ti)資(zi)產減(jian)(jian)(jian)值損失(shi)金額(e)共計3.09億(yi)元，主要為(wei)控股子公(gong)(gong)(gong)司(si)(si)珠海市麗(li)珠單抗生物(wu)技術有限公(gong)(gong)(gong)司(si)(si)的(de)(de)存(cun)(cun)貨減(jian)(jian)(jian)值損失(shi)。本次(ci)計提(ti)資(zi)產減(jian)(jian)(jian)值準備將減(jian)(jian)(jian)少公(gong)(gong)(gong)司(si)(si)2023年(nian)(nian)度歸屬于(yu)母(mu)公(gong)(gong)(gong)司(si)(si)股東的(de)(de)凈利潤1.78億(yi)元。